Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations-Reference-Cited by-同舟云学术

Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations

Published:2022-10-07 Issue:11 Volume:127 Page:1963-1973
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Jacot William^ORCID,Lusque Amélie,Vicier Cécile,Mailliez Audrey,de La Motte Rouge Thibault,Cabel Luc^ORCID,Levy Christelle,Patsouris Anne,Desmoulins Isabelle,Uwer Lionel,Thery Jean-Christophe,Robain Mathieu,Caron Olivier,Tredan Olivier,Filleron Thomas,Frenel Jean-Sébastien,Delaloge Suzette^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s41416-022-02003-1.pdf

Reference40 articles.

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.

2. Engel C, Fischer C. Breast cancer risks and risk prediction models. Breast Care. 2015;10:7–12.

3. Armstrong N, Ryder S, Forbes C, Ross J, Quek RG. A systematic review of the international prevalence of BRCA mutation in breast cancer. Clin Epidemiol. 2019;11:543–61.

4. Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007;13:4429–34.

5. Elias AD. Triple-negative breast cancer: a short review. Am J Clin Oncol. 2010;33:637–45.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PARP inhibitor resistant BRCA-mutated advanced breast cancer: current landscape and emerging treatments;Current Opinion in Oncology;2024-08-23

2. Platinum-based chemotherapy and PARP inhibitors for patients with a germline BRCA pathogenic variant and advanced breast cancer (LATER-BC): retrospective multicentric analysis of post-progression treatments;European Journal of Cancer;2023-09

3. New insights in aptamer-targeted nanoliposomes for the treatment of breast cancer;Journal of Drug Delivery Science and Technology;2023-09